Our Insights section curates articles by our Research team with additional contributions from industry experts, academics and authors.
In our latest quarterly podcast investment managers Paul Loudon and Lindsay Scott discuss the ground-breaking and often controversial obesity drugs that have been developed by Novo Nordisk and Eli Lilly. They also consider current goings-on in China and share insights from recent research debates.
19 minute listen
A little-know company in the Netherlands has emerged as a vital linchpin in the semiconductor industry.
6 minute read
Energy economist and historian, Peter Tertzakian summarises his thoughts on investing in energy today. The outlook is undoubtedly uncertain but sharing lessons from history and appreciation of the risks, Peter shared his optimism around the change to come, and the investment opportunities.
5 minute watch
“Artificial intelligence” and talk of its ground-breaking capabilities have been around for decades. Almost every company talks the talk around generative AI. But which are the companies making genuine advancements with the technology and how is it going to be transformational for their business?
7 minute read
Corporate Japan has long lagged its developed world peers in IT investment. That’s set to change as the country looks to overcome its demographic challenges and boost productivity. For OBIC, this shift in corporate mindset should prove a powerful long-term growth opportunity.
5 minute read